Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

Deals

Daily deal net: January 22, 2020
22nd January 2020
Callum Cyrus
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Revolution Medicines to rule with $100m IPO
22nd January 2020
Thierry Heles
Revolution Medicines, based on research from University of Illinois at Urbana-Champaign, Stanford University and UC Berkeley, has filed for a $100m initial public offering.
Skylo escapes stealth with $116m
21st January 2020
Robert Lavine
SoftBank has led a $103m series B round for the IoT network and hub developer, a spinout of Stanford, that made up one of two rounds it has raised.
Daily deal net: January 21, 2020
21st January 2020
Callum Cyrus
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
HepaRegenix heaps on $12.2m
21st January 2020
Callum Cyrus
University Hospital Tübingen's liver disease treatment spinout HepaRegenix has raised $21.6m in all following a series B round that will fund trials of its first candidate.
Soft Robotics handles $23m series B
21st January 2020
Callum Cyrus
Harvard-founded industrial robot supplier Soft Robotics welcomed corporates Yamaha, Honeywell, Fanuc and Tekfen for its series B round.
Daily deal net: January 20, 2020
20th January 2020
Callum Cyrus
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Daily deal net: January 17, 2020
17th January 2020
Callum Cyrus
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

News Continued

ActionIQ packs $32m into series C
17th January 2020
Robert Lavine
March Capital has led a round that boosted the overall funding for the Stanford-backed enterprise data management platform to $75m.
Bioskryb amplifies fresh funding
17th January 2020
Callum Cyrus
Wilson Sonsini Goodrich & Rosati has invested in genomic sequencing amplification business Bioskryb, co-founded by Stanford faculty member Charles Gawad.
Zinier fields investors for $90m series C
17th January 2020
Robert Lavine
Stanford-StartX's Zinier took its overall funding to $120m in a round that included returning investor Qualcomm Ventures, with the cash to go to international growth and product development.
Daily deal net: January 16, 2020
16th January 2020
Callum Cyrus
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Apple expends $200m on Xnor.ai acquisition
16th January 2020
Thierry Heles
The edge computing technology developer has reportedly been purchased by Apple, three years after being spun out of AI2 to advance work by University of Washington's Ali Farhadi.
Nicoya plays coy for $10m
16th January 2020
Callum Cyrus
UW spinout Nicoya has its sight set on product development and business expansion after a series A round featuring UW Student Venture Fund and Wilfrid Laurier University’s Startup Fund.

Editor's Picks

Big deal: Oxford PV begins capturing series D
18th March 2019
Thierry Heles
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Big deal: Ribon ties together $65m series B
7th January 2019
Thierry Heles
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Otsuka takes up Veryan’s acquisition offer
17th December 2018
Callum Cyrus
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
5th November 2018
Thierry Heles
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
© 2020 Mawsonia Ltd. All rights reserved.
test reg

Login

Forgot password?

Not yet subscribed?

See your subscription offers here